These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 30702751)

  • 21. Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.
    Hoozemans JJ; Veerhuis R; Rozemuller JM; Eikelenboom P
    CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):57-67. PubMed ID: 21143138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroimmunomodulation in the pathogenesis of Alzheimer's disease.
    Morales I; Farías G; Maccioni RB
    Neuroimmunomodulation; 2010; 17(3):202-4. PubMed ID: 20134203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microglial dysfunction connects depression and Alzheimer's disease.
    Santos LE; Beckman D; Ferreira ST
    Brain Behav Immun; 2016 Jul; 55():151-165. PubMed ID: 26612494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
    Cai Z; Hussain MD; Yan LJ
    Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GPR84 deficiency reduces microgliosis, but accelerates dendritic degeneration and cognitive decline in a mouse model of Alzheimer's disease.
    Audoy-Rémus J; Bozoyan L; Dumas A; Filali M; Lecours C; Lacroix S; Rivest S; Tremblay ME; Vallières L
    Brain Behav Immun; 2015 May; 46():112-20. PubMed ID: 25637481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microglia-Based Phenotypic Screening Identifies a Novel Inhibitor of Neuroinflammation Effective in Alzheimer's Disease Models.
    Zhou W; Zhong G; Fu S; Xie H; Chi T; Li L; Rao X; Zeng S; Xu D; Wang H; Sheng G; Ji X; Liu X; Ji X; Wu D; Zou L; Tortorella M; Zhang K; Hu W
    ACS Chem Neurosci; 2016 Nov; 7(11):1499-1507. PubMed ID: 27504670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's disease as an inflammatory disease.
    Bolós M; Perea JR; Avila J
    Biomol Concepts; 2017 Mar; 8(1):37-43. PubMed ID: 28231054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microglia actions in Alzheimer’s disease.
    Prokop S; Miller KR; Heppner FL
    Acta Neuropathol; 2013 Oct; 126(4):461-77. PubMed ID: 24224195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer's disease in the 3xTg-AD mouse model.
    Grimaldi A; Brighi C; Peruzzi G; Ragozzino D; Bonanni V; Limatola C; Ruocco G; Di Angelantonio S
    Cell Death Dis; 2018 Jun; 9(6):685. PubMed ID: 29880901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroinflammation in Alzheimer's Disease: The Preventive and Therapeutic Potential of Polyphenolic Nutraceuticals.
    Sawikr Y; Yarla NS; Peluso I; Kamal MA; Aliev G; Bishayee A
    Adv Protein Chem Struct Biol; 2017; 108():33-57. PubMed ID: 28427563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the innate immune system in Alzheimer's disease and frontotemporal lobar degeneration: an eye on microglia.
    Ridolfi E; Barone C; Scarpini E; Galimberti D
    Clin Dev Immunol; 2013; 2013():939786. PubMed ID: 23970926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease.
    Villegas-Llerena C; Phillips A; Garcia-Reitboeck P; Hardy J; Pocock JM
    Curr Opin Neurobiol; 2016 Feb; 36():74-81. PubMed ID: 26517285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microglia and Alzheimer's disease pathogenesis.
    Streit WJ
    J Neurosci Res; 2004 Jul; 77(1):1-8. PubMed ID: 15197750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Microglia in Sporadic Alzheimer's Disease.
    Streit WJ; Khoshbouei H; Bechmann I
    J Alzheimers Dis; 2021; 79(3):961-968. PubMed ID: 33361603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease.
    Thawkar BS; Kaur G
    J Neuroimmunol; 2019 Jan; 326():62-74. PubMed ID: 30502599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.
    Bamberger ME; Landreth GE
    Microsc Res Tech; 2001 Jul; 54(2):59-70. PubMed ID: 11455613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide.
    Lue LF; Walker DG
    J Neurosci Res; 2002 Nov; 70(4):599-610. PubMed ID: 12404514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicroglia antibodies in sera of Alzheimer's disease patients.
    Lemke MR; Glatzel M; Henneberg AE
    Biol Psychiatry; 1999 Feb; 45(4):508-11. PubMed ID: 10071725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microglial activation occurs late during preclinical Alzheimer's disease.
    Streit WJ; Braak H; Del Tredici K; Leyh J; Lier J; Khoshbouei H; Eisenlöffel C; Müller W; Bechmann I
    Glia; 2018 Dec; 66(12):2550-2562. PubMed ID: 30417428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microglia in Alzheimer's disease: A multifaceted relationship.
    ElAli A; Rivest S
    Brain Behav Immun; 2016 Jul; 55():138-150. PubMed ID: 26254232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.